LENZ Therapeutics, Inc.
LENZ · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $614,384 | $100,998 | $123,152 | $487,540 |
| - Cash | $20,158 | $35,140 | $47,730 | $376,976 |
| + Debt | $1,381 | $362 | $5,794 | $0 |
| Enterprise Value | $595,607 | $66,220 | $81,216 | $110,564 |
| Revenue | $0 | $0 | $15,000 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | -$58 | $0 | $15,000 | -$734 |
| % Margin | – | – | 100% | – |
| EBITDA | -$49,710 | -$72,414 | -$10,475 | -$70,026 |
| % Margin | – | – | -69.8% | – |
| Net Income | -$49,769 | -$69,968 | -$10,811 | -$70,760 |
| % Margin | – | – | -72.1% | – |
| EPS Diluted | -2.34 | -15.3 | -12.891 | -8.538 |
| % Growth | 84.7% | -18.7% | -51% | – |
| Operating Cash Flow | -$59,391 | -$60,380 | -$87,980 | -$52,852 |
| Capital Expenditures | -$468 | -$30 | -$6,594 | -$5,740 |
| Free Cash Flow | -$59,859 | -$60,410 | -$94,574 | -$58,592 |